Some people with cystic fibrosis (CF) have levels of sweat chloride above the cut-off for a diagnosis of the…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
BiomX and Adaptive Phage Therapeutics (APT) are entering into a merger agreement with a goal of pooling resources to advance…
The Cystic Fibrosis Foundation (CFF) is encouraging individuals and nonprofits to apply by April 5 for one of its…
In children with cystic fibrosis (CF) treated with Orkambi (ivacaftor/lumacaftor), the levels of the medication reached in the blood depend…
Certain markers of inflammation found deep in the lungs of children with cystic fibrosis (CF) can…
Between 2011 and 2021, improving lung function and better survival rates were consistently seen among people with cystic fibrosis…
The antibiotic arenicin may be effective at killing resistant Mycobacterium abscessus, a type of bacteria that can cause…
Staying physically active, especially engaging in more vigorous exercise regularly, is important for lung health and life quality in adolescents…
No significant link was seen between an increase in body mass index (BMI), a measure of body fat based on…
Discontinuing dornase alfa while on Trikafta (elexacaftor/tezacaftor/ivacaftor) could cut down on prescription costs by more than $1 billion each…